3,4-dihydroxyphenylacetic acid has been researched along with Obesity in 14 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "When the hypothalamic ventromedial nucleus and arcuate nucleus were destroyed in rats by treatment with monosodium glutamate in the neonatal stage, increase in the Lee index (body weight 1/3/body length) and in retroperitoneal fat as well as decreases in spontaneous motor activity, food consumption and growth hormone secretion function associated with hypothalamic low body length obesity (monosodium glutamate-treated obesity; MSG-OB) were observed as these rats grew." | 7.70 | Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines. ( Gomita, Y; Nakagawa, T; Ohyama, T; Okamura, H; Ukai, K, 2000) |
| "When the hypothalamic ventromedial nucleus and arcuate nucleus were destroyed in rats by treatment with monosodium glutamate in the neonatal stage, increase in the Lee index (body weight 1/3/body length) and in retroperitoneal fat as well as decreases in spontaneous motor activity, food consumption and growth hormone secretion function associated with hypothalamic low body length obesity (monosodium glutamate-treated obesity; MSG-OB) were observed as these rats grew." | 3.70 | Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines. ( Gomita, Y; Nakagawa, T; Ohyama, T; Okamura, H; Ukai, K, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Valent, D | 1 |
| Arroyo, L | 1 |
| Fàbrega, E | 1 |
| Font-I-Furnols, M | 1 |
| Rodríguez-Palmero, M | 1 |
| Moreno-Muñoz, JA | 1 |
| Tibau, J | 1 |
| Bassols, A | 1 |
| Carlin, J | 1 |
| Hill-Smith, TE | 1 |
| Lucki, I | 1 |
| Reyes, TM | 1 |
| Zhang, C | 1 |
| Wei, NL | 1 |
| Wang, Y | 1 |
| Wang, X | 1 |
| Zhang, JG | 1 |
| Zhang, K | 1 |
| Anderzhanova, E | 1 |
| Covasa, M | 1 |
| Hajnal, A | 1 |
| Orosco, M | 6 |
| Rouch, C | 5 |
| Meile, MJ | 2 |
| Nicolaidis, S | 4 |
| Gerozissis, K | 1 |
| Lemierre, S | 1 |
| Nakagawa, T | 1 |
| Ukai, K | 1 |
| Ohyama, T | 1 |
| Gomita, Y | 1 |
| Okamura, H | 1 |
| Kishi, E | 1 |
| Takahashi, A | 1 |
| Ishimaru, H | 1 |
| Ikarashi, Y | 1 |
| Maruyama, Y | 1 |
| Gripois, D | 1 |
| Blouquit, MF | 1 |
| Roffi, J | 1 |
| Jacquot, C | 2 |
| Cohen, Y | 2 |
| Shimizu, H | 1 |
| Shimomura, Y | 1 |
| Takahashi, M | 1 |
| Uehara, Y | 1 |
| Fukatsu, A | 1 |
| Sato, N | 1 |
| Dawson, R | 1 |
| Callahan, MF | 1 |
| Annau, Z | 1 |
| Trouvin, JH | 1 |
14 other studies available for 3,4-dihydroxyphenylacetic acid and Obesity
| Article | Year |
|---|---|
Effects of a high-fat-diet supplemented with probiotics and ω3-fatty acids on appetite regulatory neuropeptides and neurotransmitters in a pig model.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Appetite Regulation; Diet, High-Fat; Dietary Supplements; D | 2020 |
Reversal of dopamine system dysfunction in response to high-fat diet.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Diet, High-Fat; Dieta | 2013 |
Deep brain stimulation of the nucleus accumbens shell induces anti-obesity effects in obese rats with alteration of dopamine neurotransmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Deep Brain Stimulation; Dopamine; Eating; Male; Nucleus Acc | 2015 |
Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Body Weight; Diabetes Mellitus, Type 2; Dopami | 2007 |
Spontaneous feeding-related monoamine changes in rostromedial hypothalamus of the obese Zucker rat: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Dopamine; Dorsomedial Hypothalamic Nuc | 1995 |
Hypothalamic monoamines and insulin in relation to feeding in the genetically obese Zucker rat as revealed by microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Dialysis; Dopamine; Food; Glucose; Hyd | 1995 |
Rostromedial hypothalamic monoamine changes in response to intravenous infusions of insulin and glucose in freely feeding obese Zucker rats: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Blood Glucose; Dialysis; Dopamine; Eat | 1996 |
Combined effect of obesity and aging on feeding-induced monoamine release in the rostromedial hypothalamus of the Zucker rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Biogenic Monoamines; Dopamine; Eating; Food; Hydroxy | 1998 |
Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adipose Tissue; Animals; Animals, Newborn; Appetite Depressants; Arc | 2000 |
Development of obesity and neurochemical backing in aurothioglucose-treated mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Antineoplastic Combined Chemotherapy Protoco | 2001 |
Effects of insulin on brain monoamine metabolism in the Zucker rat: influence of genotype and age.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Biogenic Monoamines; Blood Glucose; Body Weigh | 1991 |
Altered ambulatory activity and related brain monoamine metabolism in genetically obese Zucker rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Chromatography, High Pressure L | 1991 |
Hypothalamic monoamine metabolism in mice: evaluation of drug challenges and neurotoxic insult.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Animals, Newborn; Dopamine; Female; G | 1986 |
Ontogeny of brain monoamines in lean and obese female Zucker rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Biogenic Amines; Brain Chemistry; Dopamine; Fe | 1986 |